Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07683117 · ClinicalTrials.gov registry record · NA
PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)
A NA study, sponsored by EMPOWERX.
- Recruiting
- Registry status
- NA
- Development phase
- 195
- Enrollment target
NCT07683117: Recruiting NA study, sponsored by EMPOWERX.
NCT07683117 is a NA study that is actively recruiting participants, run by EMPOWERX. The registered enrollment target is 195 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07683117, a NA study, is actively recruiting participants, sponsored by EMPOWERX.
- RECRUITING
- Registry status
- NA
- Development phase
- 195 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if use of the PEPPI software can improve pharmacist-provided HIV prevention (PEP/PrEP) services. The main questions it aims to answer are: 1. Does the PEPPI software make it easier for pharmacists to provide PEP/PrEP services in their pharmacy? 2. Does the PEPPI software make it easier for patients to access PEP/PrEP? Researchers will compare pharmacists' implementation and patients' access when using the PEPPI software and when not using the PEPPI software to see if the software improves implementation and access. Participants will include pharmacists and patients. Pharmacists will be asked to provide PEP/PrEP services as normal while using the PEPPI software. Patients will be asked to receive PEP/PrEP services from a pharmacist as normal, while using the PEPPI software.
Primary Outcome
Implementation outcomes will focus on how the service (pharmacist-prescribed PEP/PrEP services) is implemented. Name of the Measurement: Implementation - Service Characteristics Measurement Tool: Pharmacy Service Characteristics Questionnaire Unit of Measure: -Number of pharmacists involved in providing birth control services
Interventions
- OTHER PEPPI Pharmacies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2026-08 |
| Est. Completion | 2028-09 |
| Phase | NA |
What NCT07683117 shows while recruiting
NCT07683117 is an interventional study that assigns participants to a tested intervention. The registered 195 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which PEPPI Pharmacies is the first listed.
NCT07683117 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07683117 about?
NCT07683117 is a clinical study titled "PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)". The goal of this clinical trial is to learn if use of the PEPPI software can improve pharmacist-provided HIV prevention (PEP/PrEP) services. The main questions it aims to answer are: 1. Does the PEPPI software make it easier for pharmacists to provide PEP/PrEP services in their pharmacy? 2. Does th...
What is the current status of trial NCT07683117?
This trial is currently recruiting. It is a NA study. The enrollment target is 195 participants. The study started on 2026-08. Estimated completion is 2028-09.
What interventions are being tested in trial NCT07683117?
The interventions under investigation include: PEPPI Pharmacies (OTHER).
Who is sponsoring clinical trial NCT07683117?
This trial is sponsored by EMPOWERX, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07683117's enrollment target sits among peer trials
195 567th of 2000 higher than 1,433 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276922 · 195 participants · NA
Creative Arts Program to Reduce Burnout in Healthcare Professionals
- NCT04829357 · 195 participants
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
- NCT05054738 · 195 participants · NA
CRP and S&A for Inpatient Veterans
- NCT05561595 · 195 participants · NA
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia